Global X China Biotech ETF | 2820

High RiskEquity
Global X China Biotech ETF
Issued by:Global X
Exchange : HKEX
Unit Price (NAV) :
HKD
Minimum investment: 50 units
Share
Compare
Share
Compare
Global X China Biotech ETF | 2820

Global X China Biotech ETF | 2820

About 2820 ETF

Overview:
The Global X China Biotech ETF invests in Chinese companies which are active in the field of biotechnology.

About the Fund Manager:
Founded in 2008, Global X Funds is a New York based provider of exchange-traded funds that facilitates access to investment opportunities across the global markets. It has more than $11 billion in managed ETF assets, across more than 60 different products.

Investment Strategy:
The Global X China Biotech ETF seeks to provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the Solactive China Biotech Index NTR.

Recommended for:
Growth

Additional Information:
1. Fund Factsheet

Returns

Performance1Y p.a
Global X China Biotech ETF41.78%

Returns Calculator

Investment ofper month
gives returns of :
at 21.43% / annum
HKDin 1 years
amount
for a time period of
time1Y
Returnsbased on historic SIP returns of 21.43% per annum
HKD
HKD
HKD+ 21.43

2820 Summary Data

Symbol 2820
Exchange XHKG
Asset class Equity

About Global X

Global X is a global provider of ETFs based in America. Founded in 2008, Global X aims to provide a line-up that spans disruptive tech, equity income, commodities, and hard-to-access emerging markets. The ETF issuer and manager is widely known for its thematic growth, income and international product suites, in addition to its core, commodities and alpha strategies. In 2018, Global X was acquired by Mirae Asset.

Global X China Biotech ETF | 2820